MRCP, MSc, MD
Reader (Clinical)
- 51cg
-
- Email Address
- carl.counsell@abdn.ac.uk
- Office Address
Room 1:009, Polwarth Building Division of Applied Health Sciences 51cg Foresterhill Aberdeen AB25 2ZD
- School/Department
- School of Medicine, Medical Sciences and Nutrition
Biography
Carl is a clinical reader and honorary consultant in neurology. He graduated in medicine from Cambridge University in 1988, did his early postgraduate medical training in London, Newcastle and Falkirk and then trained in neurology, stroke and epidemiology in Edinburgh. He spent a year in Melbourne where he specialised in movement disorders before taking up his present post in 2001. A committed Christian, he would like to have more time to serve in his church and develop his interests in Fairtrade and conservation.
Latest Publications
Personalised prediction of institutionalisation in Parkinson’s: prognostic factor identification and model development and validation using IPD meta-analysis
Parkinsonism and Related Disorders, vol. 149, 108390Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
- [ONLINE]
Prognosis in Parkinson’s disease: an individual-patient-data meta-analysis of six European incidence cohorts
Movement Disorders, vol. 41, no. 7, pp. 1798-1811Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Multi-locus genetic dosage shapes cognitive disease progression in Parkinson’s patients: 15-year meta-analysis of 24 cohorts
npj Parkinson's DiseaseContributions to Journals: Articles- [ONLINE] DOI:
Digitally enabled therapy for chronic tic disorders and Tourette Syndrome: a systematic review and economic evaluation
Health Technology Assessment, vol. 30, no. 8Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Systematic review of prognostic models in Parkinson’s disease
npj Parkinson's Disease, vol. 11, 266Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
- Research
-
Research Overview
Carl is a consultant neurologist with subspecialty interest in movement disorders. His main research interests are in evidence-based medicine and broader aspects of clinical epidemiology such as incidence and prognostic studies, particularly in relation to Parkinson's disease, other movement disorders and stroke. His team have established several cohorts of parkinsonian patients for long-term follow-up and supported a number of non-industry sponsored clinical trials and Cochrane reviews, whilst also trying to promote multidisciplinary neurology research in Aberdeen.
Research Specialisms
- Clinical Medicine
Our research specialisms are based on the Higher Education Classification of Subjects (HECoS) which is , published under the licence.
Current Research
The PINE study: a population-based incidence cohort of people with Parkinson's disease and other parkinsonian disorders, along with their carers and controls who are being followed up lifelong to establish long-term prognosis.
The Parkinson's Incidence Cohorts Collaboration: an individual patient data meta-analysis of all population- based incidence cohorts of Parkinson's disease to assess prognosis and allow prognostic modelling.
The Scottish PSP/CBD prevalence cohort: a cohort of people with two related Parkinson's plus disorders, Progressive Supranuclear Palsy and Corticobasal Degeneration as well as Parkinson's disease controls, to assess diagnostic and care pathways and prognosis.
Past Research
Cochrane systematic reviews of randomised trials in stroke care and Parkinson's disease
Prognostic modelling in acute stroke
Incidence of Parkinson's disease and other parkinsonian disorders in North-East Scotland
Prevalence of multiple sclerosis in North-East Scotland and northern isles
Randomised trial of physiotherapy for cervical dystonia
Knowledge Exchange
Member of Parkinson's Excellence Network
Collaborations
Cochrane Collaboration Stroke Review Group, Professors Charles Warlow and Peter Sandercock, University of Edinburgh, UK, 1993-98.
Scottish Audit of Intracranial Vascular Malformations, Professor Rustam Al-Shahi Salman, University of Edinburgh, UK, 2002-2014.
PDMED trial, Professor Carl Clarke, University of Birmingham, UK, 2004-2020.
Clinical trial methods in neurodegenerative diseases, Professor John Zajicek, University of Plymouth, UK, 2009-2014.
PDCOMM trial, Professor Sackley, University of Nottingham, UK, 2016-2023.
NICE technology appraisals for multiple sclerosis, Universities of Warwick and Exeter, UK, 2016-2022
Parkinson's Incidence Cohorts Collaboration, Professor Tysnes, Dr Guido Alves, Professor Lars Forsgren, Dr Caroline Williams-Gray, Dr Alison Yarnall, Universities of Stavanger (Norway), Umea (Sweden), Cambridge (UK) and Newcastle (UK), 2018 ongoing
PD Connect exercise trial, Julie Jones, Robert Gordon University, Aberdeen, UK, 2019-2022
Supervision
Dr Kate Taylor (MD), 2002-06, Incidence and prognosis of parkinsonism in north-east Scotland: a pilot study.
Clare Harris (MSc), 2006-08, PINE participants attitudes to brain donation.
Dr Robert Caslake (PhD), 2006-11, Incidence and short-term prognosis of Parkinson's disease and other parkinsonian disorders in north-east Scotland.
Dr Elizabeth Visser (MD), 2009-13, Prevalence of multiple sclerosis in northern Scotland.
Dr David McGhee (PhD), 2009-13, Improving clinical trial design in neurodegenerative diseases.
Dr Angus Macleod (PhD), 2012-15, Predicting mortality and dependency in Parkinson's disease.
Dr Diane Swallow (PhD), 2016-21, Assessing diagnostic pathways in progressive supranuclear palsy and corticobasal degeneration.
Funding and Grants
Research funding has been obtained from:
Parkinson’s UK, Scottish Chief Scientist Office, BMA Doris Hillier award, RS Macdonald Trust, BUPA Foundation, NHS Grampian endowments, Dystonia Society, National Institute for Health Research.
- Teaching
-
Teaching Responsibilities
Lectures and clinical teaching of neurology for medical and dental students.
Supervising medical student elective and MSc projects
Non-course Teaching Responsibilities
Regent to medical students
- Publications
-
Page 1 of 2 Results 1 to 100 of 199
Personalised prediction of institutionalisation in Parkinson’s: prognostic factor identification and model development and validation using IPD meta-analysis
Parkinsonism and Related Disorders, vol. 149, 108390Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
- [ONLINE]
Prognosis in Parkinson’s disease: an individual-patient-data meta-analysis of six European incidence cohorts
Movement Disorders, vol. 41, no. 7, pp. 1798-1811Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Multi-locus genetic dosage shapes cognitive disease progression in Parkinson’s patients: 15-year meta-analysis of 24 cohorts
npj Parkinson's DiseaseContributions to Journals: Articles- [ONLINE] DOI:
Digitally enabled therapy for chronic tic disorders and Tourette Syndrome: a systematic review and economic evaluation
Health Technology Assessment, vol. 30, no. 8Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Systematic review of prognostic models in Parkinson’s disease
npj Parkinson's Disease, vol. 11, 266Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Beta-adrenoceptor drugs and progression to Parkinson's disease milestones in a large pooled incident cohort
npj Parkinson's Disease, vol. 11, no. 1, pp. 198Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Dementia Risk Prediction in Early Parkinson's Disease: Validation and Genetic Integration of the Montreal Parkinson risk of dementia scale (MoPaRDS)
Journal of Parkinson's Disease, vol. 15, no. 4, pp. 868-878Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
- [ONLINE]
Accuracy of routinely collected hospital administrative discharge data and death certificate ICD-10 diagnostic coding in progressive supranuclear palsy and corticobasal syndrome: a systematic review and validation study
Journal of Neurology, vol. 271, pp. 2929-2937Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
- [ONLINE]
Total Patient Delay: A comparison of patient and clinician/health system delays in the diagnosis of progressive supranuclear palsy and corticobasal syndrome
Movement Disorders Clinical Practice, vol. 11, no. 5, pp. 478-487Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Incidence and risk factors of institutionalisation in Parkinson's disease and atypical parkinsonism
Parkinsonism & Related Disorders, vol. 118Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Progressive multifocal leukoencephalopathy associated with carbamazepine -: induced immune dysfunction and recovery after carbamazepine cessation
BMJ Case Reports, vol. 16, no. 7, e255119Contributions to Journals: Articles- [ONLINE] DOI:
- [ONLINE]
The evolution of diagnosis from symptom onset to death in progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) compared to Parkinson’s disease (PD)
Journal of Neurology, vol. 270, pp. 3464-3474Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
- [ONLINE]
Cognitive and Motor Decline in Dementia with Lewy Bodies and Parkinson's Disease Dementia
Movement Disorders Clinical Practice, vol. 10, no. 6, pp. 980-986Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
- [ONLINE]
Achieving proportionate governance review in Scotland: Threats and solutions
Journal of the Royal College of Physicians of Edinburgh, vol. 53, no. 1, pp. 74-79Contributions to Journals: Comments and Debates- [ONLINE] DOI:
- [ONLINE]
Is the assumption of waning of treatment effect applied consistently across NICE technology appraisals?: A case-study focusing on disease-modifying therapies for treatment of multiple sclerosis
International Journal of Technology Assessment in Health Care, vol. 38, no. 1, pp. e83Contributions to Journals: Review articles- [ONLINE] DOI:
- [OPEN ACCESS]
The incidence, baseline predictors and outcomes of dementia in an incident cohort of Parkinson’s disease and controls
Journal of Neurology, vol. 269, pp. 4288–4298Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
- [ONLINE]
Systematic review of prevalence studies of progressive supranuclear palsy and corticobasal syndrome
Movement Disorders Clinical Practice, vol. 9, no. 5, pp. 604-613Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Management of the first stage of convulsive status epilepticus in adults: a systematic review of current randomised evidence
Journal of Neurology, vol. 269, no. 7, pp. 3420-3429Contributions to Journals: Review articles- [ONLINE] DOI:
- [OPEN ACCESS]
- [ONLINE]
Prevalence of progressive supranuclear palsy and corticobasal syndrome in Scotland
Neuroepidemiology, vol. 56, no. 4, pp. 291–297Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
GBA and APOE Impact Cognitive Decline in Parkinson's Disease: A 10-Year Population-Based Study
Movement Disorders, vol. 37, no. 5, pp. 1016-1027Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
- [ONLINE]
Pre-hospital and emergency department treatment of convulsive status epilepticus in adults: an evidence synthesis
Health technology assessment (Winchester, England), vol. 26, no. 20, pp. 1-76Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
- [ONLINE]
Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy: The PD MED Randomized Clinical Trial
JAMA Neurology, vol. 79, no. 2, pp. 131-140Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Lack of Association Between GBA Mutations and Motor Complications in European and American Parkinson's Disease Cohorts
Journal of Parkinson's Disease, vol. 11, no. 4, pp. 1569-1578Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
First delirium episode in Parkinson’s disease and parkinsonism: incidence, predictors and outcomes
npj Parkinson's Disease, vol. 7, no. 1, 92Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Ocrelizumab not recommended in France for patients with primary progressive multiple sclerosis while recommended in England: a review comparing the assessment by HAS and NICE
Expert opinion on biological therapy, vol. 21, no. 6, pp. 741-747Contributions to Journals: Review articles- [ONLINE] DOI:
- [OPEN ACCESS]
- [ONLINE]
Association of GBA Genotype With Motor and Functional Decline in Patients With Newly Diagnosed Parkinson Disease
Neurology, vol. 96, no. 7, pp. e1036-e1044Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
- [ONLINE]
Association of SNCA Parkinson's Disease Risk Polymorphisms With Disease Progression in Newly Diagnosed Patients
Frontiers in Neurology, vol. 11, 620585Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
- [ONLINE]
Accuracy of death certificates for recording parkinsonian syndromes and associated dementia
Journal of Neurology, vol. 268, pp. 140–146Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
- [ONLINE]
Validation of a UPDRS-/MDS-UPDRS-based definition of functional dependency for Parkinson's disease
Parkinsonism & Related Disorders, vol. 76, pp. 49-53Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
- [ONLINE]
Ocrelizumab for Treating Patients with Primary Progressive Multiple Sclerosis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Pharmacoeconomics, vol. 38, no. 6, pp. 527-536Contributions to Journals: Review articles- [ONLINE] DOI:
- [ONLINE]
Treatment Responsiveness of Motor Features in Parkinson's Disease: A Matched Case‐Control Analysis
Movement Disorders Clinical Practice, vol. 7, no. 1, pp. 45-51Contributions to Journals: Articles- [ONLINE] DOI:
- [ONLINE]
Comparative effectiveness of beta-interferons and glatiramer acetate for relapsing-remitting multiple sclerosis: systematic review and network meta-analysis of trials including recommended dosages
BMC Neurology, vol. 18, 162Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Age-related selection bias in Parkinson's disease research: are we recruiting the right participants?
Parkinsonism & Related Disorders, vol. 55, pp. 128-133Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Association of glucocerebrosidase polymorphisms and mutations with dementia in incident Parkinson's disease
Alzheimer's and Dementia, vol. 14, no. 10, pp. 1293-1301Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Author response: Early weight loss in parkinsonism predicts poor outcomes: Evidence from an incident cohort study
Neurology, vol. 91, no. 6, pp. 287-287Contributions to Journals: Comments and Debates- [ONLINE] DOI:
Short and long-term clinical outcomes of use of beta-interferon or glatiramer acetate for people with clinically isolated syndrome: a systematic review of randomised controlled trials and network meta-analysis
Journal of Neurology, vol. 265, no. 5, pp. 999-1009Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Author response: Early weight loss in neurodegenerative disorders could be related to increased protein metabolism in the brain
NeurologyContributions to Journals: Comments and Debates- [ONLINE]
Development and validation of prognostic survival models in newly diagnosed Parkinson’s disease
Movement Disorders, vol. 33, no. 1, pp. 108-116Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Early weight loss in parkinsonism predicts poor outcomes: evidence from an incident cohort study
Neurology, vol. 89, no. 22, pp. 2254-2261Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
- [ONLINE]
Season of infectious mononucleosis as a risk factor for multiple sclerosis: a UK primary care case-control study
Multiple Sclerosis and Related Disorders, vol. 17, pp. 103-106Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
- [OPEN ACCESS]
- [OPEN ACCESS]
Clinical effectiveness and cost-effectiveness of beta-interferon and glatiramer acetate for treating multiple sclerosis: systematic review and economic evaluation
Health Technology Assessment, vol. 21, no. 52, pp. 1-352Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Genome-wide pleiotropy between Parkinson disease and autoimmune diseases
JAMA Neurology, vol. 74, no. 7, pp. 780-792Contributions to Journals: Articles- [ONLINE] DOI:
- [ONLINE]
Simple prediction scores predict good and devastating outcomes after stroke more accurately than physicians
Age and Ageing, vol. 46, no. 3, pp. 421-426Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Discovery and functional prioritization of Parkinson's disease candidate genes from large-scale whole exome sequencing
Genome Biology, vol. 18, no. 1, 22Contributions to Journals: Articles- [ONLINE] DOI:
- [ONLINE]
Medium-term prognosis of an incident cohort of parkinsonian patients compared to controls
Parkinsonism & Related Disorders, vol. 32, pp. 36-41Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Predictors of functional dependency in Parkinson’s disease
Movement Disorders, pp. 1482-1488Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Stroke: Are care and outcomes better for participants of stroke trials?
Nature Reviews Neurology, vol. 12, no. 9, pp. 498-499Contributions to Journals: Review articles- [ONLINE] DOI:
- [OPEN ACCESS]
Risk of fracture amongst patients with Parkinson's disease and other forms of parkinsonism
Parkinsonism & Related Disorders, vol. 29, pp. 60-65Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
- [OPEN ACCESS]
- [OPEN ACCESS]
Co-morbidity burden in Parkinson’s disease: Comparison with controls and its influence on prognosis
Parkinsonism & Related Disorders, vol. 28, pp. 124-129Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
- [OPEN ACCESS]
- [OPEN ACCESS]
A review of clinical trial designs used to detect a disease-modifying effect of drug therapy in Alzheimer's disease and Parkinson's disease
BMC Neurology, vol. 16, pp. 1-13Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
A randomized trial of specialized versus standard neck physiotherapy in cervical dystonia
Parkinsonism & Related Disorders, vol. 23, pp. 72-79Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
- [OPEN ACCESS]
- [OPEN ACCESS]
- [OPEN ACCESS]
- [OPEN ACCESS]
- [OPEN ACCESS]
- [OPEN ACCESS]
Motor complications in an incident Parkinson’s disease cohort
European Journal of Neurology, vol. 23, no. 2, pp. 304-312Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
A systematic review of loss of independence in Parkinson's disease
Journal of Neurology, vol. 263, no. 1, pp. 1-10Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
- [OPEN ACCESS]
- [OPEN ACCESS]
- [OPEN ACCESS]
- [OPEN ACCESS]
Fracture risk in incident Parkinsonian cohort versus controls
Annual Meeting of the Association-of-British-Neurologists (ABN) - 2015, pp. e4Contributions to Journals: Abstracts- [ONLINE] DOI:
Pre-hospital notification is associated with improved stroke thrombolysis timing
Journal of the Royal College of Physicians of Edinburgh, vol. 45, no. 3, pp. 190-195Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption
Molecular Psychiatry, vol. 20, no. 5, pp. 647-656Contributions to Journals: Comments and Debates- [ONLINE] DOI:
- [ONLINE]
Using 'dead or dependent' as an outcome measure in clinical trials in Parkinson's disease
Journal of Neurology, Neurosurgery & Psychiatry, vol. 86, no. 2, pp. 180-185Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Anticoagulants for acute ischaemic stroke
Cochrane Database of Systematic Reviews, no. 3, CD000024Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Mortality in Parkinson's disease: A systematic review and meta-analysis
Movement Disorders, vol. 29, no. 13, pp. 1615-1622Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Prognosis in Incident Parkinsonian Cohort: The Pine Study
Meeting of the Associatiion-of-British-Neurologists, e4Contributions to Journals: Abstracts- [ONLINE] DOI:
Progression of Disability in PD: A systematic Review
Meeting of the Associatiion-of-British-Neurologists, pp. e4Contributions to Journals: Abstracts- [ONLINE] DOI:
Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised
The Lancet, vol. 384, no. 9949, pp. 1196-1205Contributions to Journals: Articles- [ONLINE] DOI:
Conservative management vs intervention for unruptured brain arteriovenous malformations: reply
JAMA, vol. 312, no. 10, pp. 1058-1059Contributions to Journals: Comments and Debates- [ONLINE] DOI:
Age-, and gender-specific incidence of vascular parkinsonism, progressive supranuclear palsy, and parkinsonian-type multiple system atrophy in North East Scotland: The PINE study
Parkinsonism & Related Disorders, vol. 20, no. 8, pp. 834-839Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Outcome after surgical or conservative management of cerebral cavernous malformations
Neurology, vol. 83, no. 7, pp. 582-589Contributions to Journals: Articles- [ONLINE] DOI:
Oral antiplatelet therapy for acute ischaemic stroke
Cochrane Database of Systematic Reviews, no. 3, CD000029Contributions to Journals: Articles- [ONLINE] DOI:
The epidemiology of infectious mononucleosis in Northern Scotland: a decreasing incidence and winter peak
BMC Infectious Diseases, vol. 14, 151Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
A systematic review of biomarkers for disease progression in Alzheimer's disease
PloS ONE, vol. 9, no. 2, e88854Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease
Nature Genetics, vol. 46, no. 9, pp. 989-993Contributions to Journals: Articles- [ONLINE] DOI:
- [ONLINE]
Outcome after conservative management or intervention for unruptured brain arteriovenous malformations
JAMA, vol. 311, no. 16, pp. 1661-1669Contributions to Journals: Articles- [ONLINE] DOI:
The Mini-Mental Parkinson's (MMP) as a cognitive screening tool in people with Parkinson's disease
Current Aging Science, vol. 6, no. 3, pp. 273-279Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
- [OPEN ACCESS]
The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphism
Journal of Neurology, Neurosurgery and Psychiatry, vol. 84, no. 6, pp. 666-673Contributions to Journals: Articles- [ONLINE] DOI:
- [ONLINE]
Age-, gender-, and socioeconomic status-specific incidence of Parkinson's disease and parkinsonism in North East Scotland: The PINE study
Parkinsonism & Related Disorders, vol. 19, no. 5, pp. 515-521Contributions to Journals: Articles- [ONLINE] DOI:
Attitudes to brain donation for Parkinson's research and how to ask: A qualitative study with suggested guidelines for practice
Journal of Advanced Nursing, vol. 69, no. 5, pp. 1096-1108Contributions to Journals: Articles- [ONLINE] DOI:
A systematic review of biomarkers for disease progression in Parkinson's disease
BMC Neurology, vol. 13, 35Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial
The Lancet neurology, vol. 12, no. 4, pp. 339-345Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
- [ONLINE]
Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease
Human Molecular Genetics, vol. 21, no. 22, pp. 4996-5009Contributions to Journals: Articles- [ONLINE] DOI:
- [ONLINE]
Comparison of patient rated treatment response with measured improvement in Parkinson's disease
Journal of Neurology, Neurosurgery & Psychiatry, vol. 83, no. 10, pp. 1001-1005Contributions to Journals: Articles- [ONLINE] DOI:
Seizure risk with AVM treatment or conservative management: prospective, population-based study
Neurology, vol. 79, no. 6, pp. 500-507Contributions to Journals: Articles- [ONLINE] DOI:
A new prevalence study of multiple sclerosis in Orkney, Shetland and Aberdeen city
Journal of Neurology, Neurosurgery & Psychiatry, vol. 83, no. 7, pp. 719-724Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Developing predictive models of excellent and devastating outcome after stroke
Age and Ageing, vol. 41, no. 4, pp. 560-564Contributions to Journals: Articles- [ONLINE] DOI:
Season of birth and risk of developing idiopathic Parkinson's disease
Parkinsonism & Related Disorders, vol. 18, no. 5, pp. 675-676Contributions to Journals: Letters- [ONLINE] DOI:
- [OPEN ACCESS]
- [OPEN ACCESS]
Statistical analysis, trial design and duration in Alzheimer's disease clinical trials: a review
International Psychogeriatrics, vol. 24, no. 5, pp. 689-697Contributions to Journals: Articles- [ONLINE] DOI:
Fibrinogen depleting agents for acute ischaemic stroke
Cochrane Database of Systematic Reviews, no. 3, CD000091Contributions to Journals: Articles- [ONLINE] DOI:
Untreated clinical course of cerebral cavernous malformations: a prospective, population-based cohort study
The Lancet neurology, vol. 11, no. 3, pp. 217-224Contributions to Journals: Articles- [ONLINE] DOI:
Genome-wide homozygosity and multiple sclerosis in Orkney and Shetland Islanders
EJHG : European journal of human genetics : the official journal of the European Society of Human Genetics. , vol. 20, no. 2, pp. 198-202Contributions to Journals: Articles- [ONLINE] DOI:
Early Mortality in an Incident Cohort of People with Parkinson's Disease and Parkinsonism
Age and Ageing, vol. 41, pp. 67Contributions to Journals: AbstractsParkinsonism Incidence in Northeast Scotland (The Pine Study): The Incidence of Parkinson's Disease and Parkinsonism
Age and Ageing, vol. 41, no. Suppl. 1, pp. 68Contributions to Journals: Abstracts- [ONLINE] DOI:
The Incidence of Progressive Supranuclear Palsy, Multiple System Atrophy and Vascular Parkinsonism in Northeast Scotland (The Pine Study)
Age and Ageing, vol. 41, pp. 69Contributions to Journals: AbstractsSystematic review of biomarkers for disease progression in Parkinson's disease
Annual Meeting of the Association of British Neurologists, pp. e1Contributions to Journals: Abstracts- [ONLINE] DOI:
The impact of motor and non motor symptoms on health state values in newly diagnosed idiopathic Parkinson's disease
Journal of Neurology, vol. 259, no. 3, pp. 462-468Contributions to Journals: Articles- [ONLINE] DOI:
The documentation of lumbar puncture for acute headache presentations: a re-audit
International Journal of Clinical Practice, vol. 65, no. 11, pp. 1201-1202Contributions to Journals: Letters- [ONLINE] DOI:
Disease severity and progression in progressive supranuclear palsy and multiple system atrophy: validation of the NNIPPS - PARKINSON PLUS SCALE
PloS ONE, vol. 6, no. 8, e22293Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
The use of decision-analytic models in Parkinson's disease: a systematic review and critical appraisal
Applied Health Economics and Health Policy, vol. 9, no. 4, pp. 243-258Contributions to Journals: Articles- [ONLINE] DOI:
Seizure risk from cavernous or arteriovenous malformations: prospective population-based study
Neurology, vol. 76, no. 18, pp. 1548-1554Contributions to Journals: Articles- [ONLINE] DOI:
Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies
The Lancet, vol. 377, no. 9766, pp. 641-649Contributions to Journals: Articles- [ONLINE] DOI:
Orphan drugs: Regulation is flawed
BMJ (Clinical research ed.), vol. 341, c7016Contributions to Journals: Letters- [ONLINE] DOI:
Parkinsonism incidence in north-east Scotland: the PINE study
Journal of Neurology, Neurosurgery & Psychiatry, vol. 81, no. 11, pp. E21Contributions to Journals: Articles- [ONLINE] DOI:
The Incidence of Progressive Supranuclear Palsy, Multiple System Atrophy, and Vascular Parkinsonism in North-East Scotland (the PINE Study)
Movement Disorders, vol. 25, pp. S613-S614Contributions to Journals: ArticlesCognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy
Brain, vol. 133, no. 8, pp. 2382-2393Contributions to Journals: Articles- [ONLINE] DOI: